Raymond C Stevens insider trades

Open-market stock purchases and sales by Raymond C Stevens, Director at Danaher Corp /de/, from SEC Form 4 filings since Apr 28, 2017.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +140%.

Recent trades

DateStockTradeValue
Jul 31, 2026DHR Danaher Corp /de/Bought (not open market)$35.4K
May 15, 2026DHR Danaher Corp /de/Bought (not open market)—
May 15, 2026DHR Danaher Corp /de/Bought (not open market)—
Apr 24, 2026DHR Danaher Corp /de/Bought (not open market)$35.3K
Mar 19, 2026GPCR Structure Therapeutics IncBought (not open market)—
Mar 19, 2026GPCR Structure Therapeutics IncBought (not open market)—
Mar 3, 2026GPCR Structure Therapeutics IncSold (not open market)$1.1M
Jan 30, 2026DHR Danaher Corp /de/Bought (not open market)$34.7K
Nov 20, 2025GPCR Structure Therapeutics IncBought (not open market)—
Oct 31, 2025DHR Danaher Corp /de/Bought (not open market)$34.7K

Companies traded

  • DHR Danaher Corp /de/: 3 sales, last Jul 31, 2026
  • GPCR Structure Therapeutics Inc: 1 buy, 1 sale, last Mar 19, 2026

Get free alerts when Raymond C Stevens files a new trade →